MP VERSUS MPT FOR PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH MULTIPLE MYELOMA: A META ANALYSIS OF SURVIVAL OF 1682 INDIVIDUAL PATIENT DATA FROM 6 RANDOMIZED CLINICAL TRIALS

被引：0
|
作者：
Waage, A. [1 ]
Palumbo, A. [2 ]
Hulin, C. [1 ]
Beksac, M. [3 ]
Fayers, P. [4 ]
Mary, J. Y. [5 ]
Bringhen, S. [2 ]
Sonneveld, P. [6 ]
Wijermans, P. [7 ]
Facon, T. [8 ]
机构：
[1] Dept Hematol, Trondheim, Norway
[2] Univ Turin, Div Ematol, Turin, Italy
[3] Ankara Univ, TR-06100 Ankara, Turkey
[4] Univ Aberdeen, Aberdeen, Scotland
[5] INSERM, U717, Paris, France
[6] Erasmus MC, Rotterdam, Netherlands
[7] Leyenburg Hosp, The Hague, Netherlands
[8] CHU Lille, Serv Malad Sang, F-59037 Lille, France
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0567
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [1] Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
    Fayers, Peter M.
    Palumbo, Antonio
    Hulin, Cyrille
    Waage, Anders
    Wijermans, Pierre
    Beksac, Meral
    Bringhen, Sara
    Mary, Jean-Yves
    Gimsing, Peter
    Termorshuizen, Fabian
    Haznedar, Rauf
    Caravita, Tommaso
    Moreau, Philippe
    Turesson, Ingemar
    Musto, Pellegrino
    Benboubker, Lotfi
    Schaafsma, Martijn
    Sonneveld, Pieter
    Facon, Thierry
    BLOOD, 2011, 118 (05) : 1239 - 1247
  • [2] MP versus M PT for previously untreated elderly patients with multiple myeloma: A meta-analysis of 1,682 individual patient data from six randomized clinical trials
    Waage, A.
    Palumbo, A. P.
    Fayers, P.
    Beksac, M.
    Hulin, C.
    Mary, J.
    Bringhen, S.
    Sonneveld, P.
    Wijermans, P.
    Facon, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Melphalan and Prednisone (MP) Versus Melphalan, Prednisone and Thalidomide (MPT) as Initial Therapy for Previously Untreated Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials
    Kapoor, Prashant
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Lacy, Martha Q.
    Dingli, David
    Kyle, Robert
    Gertz, Morie A.
    Greipp, Philip R.
    Kumar, Shaji
    Mandrekar, Sumithra J.
    BLOOD, 2009, 114 (22) : 254 - 255
  • [4] Thalidomide treatment for patients with previously untreated multiple myeloma: a meta-analysis of randomized controlled trials
    Gao, Minjie
    Kong, Yuanyuan
    Wang, Houcai
    Xie, Bingqian
    Yang, Guang
    Gao, Lu
    Zhang, Yiwen
    Zhan, Fenghuang
    Dai, Bojie
    Tao, Yi
    Shi, Jumei
    TUMOR BIOLOGY, 2016, 37 (08) : 11081 - 11098
  • [5] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zeng, Zhiyong
    Lin, Junfang
    Chen, Junmin
    ANNALS OF HEMATOLOGY, 2013, 92 (07) : 935 - 943
  • [6] Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
    Zhiyong Zeng
    Junfang Lin
    Junmin Chen
    Annals of Hematology, 2013, 92 : 935 - 943
  • [7] Efficacy of Carfilzomib in the Treatment of Relapsed and (or) Refractory Multiple myeloma: a Meta Analysis of Individual Patient Data from Clinical Trials
    Chen, Runzhe
    Chen, Baoan
    Ge, Zheng
    BLOOD, 2016, 128 (22)
  • [8] Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
    Palumbo, Antonio
    Waage, Anders
    Hulin, Cyrille
    Beksac, Meral
    Zweegman, Sonja
    Gay, Francesca
    Gimsing, Peter
    Leleu, Xavier
    Wijermans, Pierre
    Sucak, Gulsan
    Pezzatti, Sara
    Juliusson, Gunnar
    Pegourie, Brigitte
    Schaafsma, Martijn
    Galli, Monica
    Turesson, Ingemar
    Kolb, Brigitte
    van der Holt, Bronno
    Baldi, Ileana
    Rolke, Jurgen
    Ciccone, Giovannino
    Wetterwald, Marc
    Lokhorst, Henk
    Boccadoro, Mario
    Rodon, Philippe
    Sonneveld, Pieter
    HAEMATOLOGICA, 2013, 98 (01) : 87 - 94
  • [9] Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
    Bringhen, Sara
    Victoria Mateos, Maria
    Zweegman, Sonja
    Larocca, Alessandra
    Falcone, Antonietta Pia
    Oriol, Albert
    Rossi, Davide
    Cavalli, Maide
    Wijermans, Pierre
    Ria, Roberto
    Offidani, Massimo
    Jose Lahuerta, Juan
    Liberati, Anna Marina
    Mina, Roberto
    Callea, Vincenzo
    Schaafsma, Martijn
    Cerrato, Chiara
    Marasca, Roberto
    Franceschini, Luca
    Evangelista, Andrea
    Teruel, Ana-Isabel
    van der Holt, Bronno
    Montefusco, Vittorio
    Ciccone, Giovannino
    Boccadoro, Mario
    San Miguel, Jesus
    Sonneveld, Pieter
    Palumbo, Antonio
    HAEMATOLOGICA, 2013, 98 (06) : 980 - 987
  • [10] Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials
    Jones, Ashley P.
    Riley, Richard D.
    Williamson, Paula R.
    Whitehead, Anne
    CLINICAL TRIALS, 2009, 6 (01) : 16 - 27
12345